Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
TRAW
TRAW
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TRAW News
Healthcare Stocks Decline Late Friday Afternoon
2d ago
Yahoo Finance
Traws Pharma Advances Hantavirus Treatment Development
3d ago
stocktwits
Traws Pharma Advances Hantavirus Treatment Candidates Amid Rising Threats
3d ago
Newsfilter
TRAW Reports 2025 Financials and $60 Million Financing Plan
Apr 16 2026
Yahoo Finance
Traws Pharma Secures $60 Million Financing for Flu Program Advancement
Apr 16 2026
seekingalpha
Traws Pharma Reports FY Earnings and Financing Plan
Apr 15 2026
seekingalpha
Traws Pharma Secures $60 Million PIPE Financing
Apr 15 2026
NASDAQ.COM
Traws Pharma Announces Clinical Results for Ratutrelvir with Promising Efficacy
Feb 19 2026
Newsfilter
Traws Pharma Advances Ratutrelvir COVID-19 Trial
Jan 26 2026
stocktwits
Traws Pharma Reports Clinical Progress on Ratutrelvir and Tivoxavir Marboxil
Jan 26 2026
Newsfilter
Plus Therapeutics Prices Public Offering, Raising $15 Million
Jan 15 2026
NASDAQ.COM
Traws Pharma's Oral COVID Treatment Demonstrates Results Similar to Paxlovid
Dec 17 2025
Benzinga
Traws Pharma's Ratutrelvir Shows Favorable Tolerability in COVID-19 Treatment
Dec 17 2025
Globenewswire
Traws Pharma's Ratutrelvir Shows Favorable Tolerability in COVID-19 Treatment
Dec 17 2025
Newsfilter
Market Update: Tilray Drives After-Hours Gains as Biotech Stocks Soar
Dec 15 2025
NASDAQ.COM
Linde Analyst Starts Coverage Optimistically; Check Out the Top 5 Initiations for Wednesday
Dec 03 2025
Benzinga
Show More News
